Advanced Composites Explained

Advanced Composites Explained

Advanced Composites Explained

Advanced Composites Explained

Advanced Composites Explained

New Versaflex™ HC overmolding thermoplastic elastomers (TPEs) for medical device housings offer enhanced resistance to commonly used antiseptic cleaners. Caption: New Versaflex™ HC overmolding thermoplastic elastomers (TPEs) for device housings offer enhanced resistance to commonly used antiseptic cleaners used in hospitals. Media contact Sandy Wagner Marketing Communications Manager PolyOne GLS Thermoplastic Elastomers +1 815-759-2676 sandy.wagner@avient.com

To create a softer surface, many textile manufacturers are brushing fibers. No ink is applied to the fabric, but this step lays down fibers and creates a smoother surface, eliminating the need for an extra print stroke.

Composition of the Board, director responsibilities, access to management and independent advisors, director compensation, and director orientation and continuing education

First quarter 2021 GAAP EPS from continuing operations was $0.86 compared to $0.38 in the prior year first quarter. Demand conditions were robust in the quarter, in particular for composite technologies and new business gains in healthcare applications. Patterson said, “As more and more vaccines are administered, we anticipate demand conditions will continue to improve.

Sustainable infrastructure solutions that increase energy efficiency, renewable energy, natural resource conservation and fiber optic / 5G network accessibility Factors that could cause actual results to differ materially from those implied by these forward-looking statements include disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows including without any limitation, any supply chain and logistics issues; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Color business, including any expected synergies; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; our ability to continue to pay regular quarterly cash dividends, including at the increased rate, and the amounts and timing of any future dividends; information systems failures and cyberattacks; our ability to consummate and successfully integrate acquisitions; and amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions.